Schointuch, M. N., Gilliam, T. P., Stine, J. E., Han, X., Zhou, C., Gehrig, P. A., . . . Bae-Jump, V. L. (2014). Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer().

Schointuch, Monica N., Timothy P. Gilliam, Jessica E. Stine, Xiaoyun Han, Chunxiao Zhou, Paola A. Gehrig, Kenneth Kim, and Victoria L. Bae-Jump. Simvastatin, an HMG-CoA Reductase Inhibitor, Exhibits Anti-metastatic and Anti-tumorigenic Effects in Endometrial Cancer(). 2014.

Schointuch, Monica N., et al. Simvastatin, an HMG-CoA Reductase Inhibitor, Exhibits Anti-metastatic and Anti-tumorigenic Effects in Endometrial Cancer(). 2014.